Early Methylene Blue in the Microhemodynamics of Septic Shock Patients
Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the viability and feasibility of the study protocol in order to conduct a larger clinical trial, assessing the microhemodynamic response to methylene blue infusion, through the capillary refill time measure, in septic shock patients.
Phase:
PHASE2
Details
Lead Sponsor:
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
Collaborator:
Irmandade da Santa Casa de Misericordia de Curitiba